2024-09-23 - Analysis Report
## AbbVie Inc. (ABBV) Stock Analysis

**Company Overview:** AbbVie Inc. is a research-based global biopharmaceutical company that develops, manufactures, and markets a range of healthcare products.

**1. Performance Comparison:**

* **Cumulative Return:** ABBV (152.17%) outperformed the S&P 500 (VOO) (132.53%) by 19.64%. 
* **Relative Strength:**  ABBV's current relative strength stands at 60.86%, suggesting it is performing better than the S&P 500 but not at its peak historical outperformance level.

**2. Recent Price Movement:**

* **Closing Price:** $193.47
* **5-Day Moving Average:** $193.65
* **20-Day Moving Average:** $195.28
* **60-Day Moving Average:** $185.35

This suggests a slight downward trend in the short term, with the price currently below the 5-day and 20-day moving averages but above the 60-day moving average.

**3. Technical Indicators:**

* **RSI:** 43.94 - Indicates that the stock is currently in the neutral territory, not considered overbought or oversold.
* **PPO:** -0.46 - A negative PPO value suggests a bearish trend, indicating a potential downward movement.
* **Delta_Previous_Relative_Divergence:** -8.74 -  A negative value indicates that the relative strength of ABBV has declined recently. 
* **Expected Return:** 24.47% - This is the estimated maximum potential return for a 5-year investment in ABBV.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-07-25 | 2.65 | 2.57 |
| 2024-04-26 | 2.31 | 2.26 |
| 2024-02-02 | 2.79 | 2.76 |
| 2023-10-27 | 2.95 | 2.86 |
| 2023-07-27 | 2.91 | 2.79 |

The most recent earnings report (2024-07-25) showed that ABBV exceeded analysts' expectations by 0.08 per share.  This suggests that the company is performing well and exceeding market expectations.

**5. Overall Analysis:**

ABBV has historically outperformed the S&P 500, but recent technical indicators suggest a potential short-term downtrend. Despite this, its strong recent earnings and positive outlook point to continued growth potential. The stock is currently in neutral territory, with its price fluctuating around its moving averages.

**6. Conclusion:**

ABBV is a company with a strong history of exceeding earnings expectations and demonstrating growth. However, its recent price movement and technical indicators suggest a potential short-term dip. Investors may want to consider monitoring the stock closely and looking for potential entry points if the price drops further, or waiting for stronger signals of a potential rebound. 
